Latest Asx News

White Cliff Minerals has reported a landmark copper intersection at its Rae Copper Project in Nunavut, Canada, with drill hole DAN25008 delivering 175 metres at 2.5% copper from near surface. This discovery signals a major step forward in defining a potentially world-class copper resource.

Premier1 Lithium’s first reverse circulation drilling program at the Yalgoo Project has confirmed multiple high-grade gold intersections, revealing both extensions of known mineralisation and new targets.

Kingsland Minerals has appointed GR Engineering Services to lead a scoping study for its Leliyn Graphite Project, aiming to unlock the economic potential of one of Australia’s largest graphite resources. The study, supported by new project management expertise and existing off-take agreements, is set to complete by year-end.

Southern Cross Media Group reports robust audio revenue growth exceeding expectations and signals a return to dividends for FY25, underpinned by disciplined cost management.

EZZ Life Science Holdings Limited has announced a fully franked ordinary dividend of AUD 0.02 per share for the six months ending December 2024, signaling steady returns for shareholders.

Biome Australia is expanding its health portfolio with Activated Therapeutics, a new practitioner-only brand launching four evidence-based natural medicine products in Q4 2025.

Ioneer Ltd reveals promising Falcon gravity concentration testwork results that enhance lithium grade and yield at its Rhyolite Ridge project, underpinning future expansion potential.

Vinyl Group Ltd has raised $1.21 million through the exercise of options by key investors, eliminating all convertible notes and strengthening its balance sheet.

Seven West Media has agreed to acquire Southern Cross Media's television licences, completing its national broadcast network and boosting its digital and live TV offerings across Australia.

Southern Cross Media Group has agreed to sell its remaining television assets to Seven West Media, marking its full exit from TV and a sharpened focus on audio.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.

Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.